Results 261 to 270 of about 99,250 (279)
Some of the next articles are maybe not open access.

Global burden of chikungunya virus infections and the potential benefit of vaccination campaigns

Nature Medicine
The first vaccine against chikungunya virus (CHIKV) has now been licensed; however, due to a limited knowledge of the underlying global burden, its potential to reduce disease burden remains unknown.
Gabriel Ribeiro dos Santos   +15 more
semanticscholar   +1 more source

Chikungunya Virus Vaccines: A Review of IXCHIQ and PXVX0317 from Pre-Clinical Evaluation to Licensure

BioDrugs
Chikungunya virus is an emerging mosquito-borne alphavirus that causes febrile illness and arthritic disease. Chikungunya virus is endemic in 110 countries and the World Health Organization estimates that it has caused more than 2 million cases of ...
W. Weber, D. Streblow, Lark L. Coffey
semanticscholar   +1 more source

From bench to clinic: the development of VLA1553/IXCHIQ, a live-attenuated chikungunya vaccine

Journal of Travel Medicine
Background Over the past 20 years, over 5 million cases of chikungunya, a mosquito-transmitted viral disease, have been reported in over 110 countries.
Lin H Chen   +4 more
semanticscholar   +1 more source

Biology and pathogenesis of chikungunya virus

Nature Reviews Microbiology, 2010
Olivier Schwartz, Matthew L Albert
exaly  

FHL1 is a major host factor for chikungunya virus infection

Nature, 2019
Laurent Meertens   +2 more
exaly  

Vaccine and Therapeutic Options To Control Chikungunya Virus

Clinical Microbiology Reviews, 2018
Ann M Powers
exaly  

Controlling vector-borne diseases by releasing modified mosquitoes

Nature Reviews Microbiology, 2018
Heather A Flores, Scott L O'neill
exaly  

Home - About - Disclaimer - Privacy